- Home
- RVNC vs UEC Comparison
RVNC vs UEC Comparison
Compare RVNC & UEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVNC
- UEC
- Stock Information
- Founded
- RVNC 1999
- UEC 2003
- Country
- RVNC United States
- UEC United States
- Employees
- RVNC N/A
- UEC N/A
- Industry
- RVNC Biotechnology: Pharmaceutical Preparations
- UEC Other Metals and Minerals
- Sector
- RVNC Health Care
- UEC Basic Materials
- Exchange
- RVNC Nasdaq
- UEC Nasdaq
- Market Cap
- RVNC 320.5M
- UEC N/A
- IPO Year
- RVNC 2014
- UEC N/A
- Fundamental
- Price
- RVNC $3.09
- UEC $7.08
- Analyst Decision
- RVNC Hold
- UEC Strong Buy
- Analyst Count
- RVNC 9
- UEC 2
- Target Price
- RVNC $8.45
- UEC $10.63
- AVG Volume (30 Days)
- RVNC 3.6M
- UEC 7.1M
- Earning Date
- RVNC 11-07-2024
- UEC 12-27-2024
- Dividend Yield
- RVNC N/A
- UEC N/A
- EPS Growth
- RVNC N/A
- UEC N/A
- EPS
- RVNC N/A
- UEC N/A
- Revenue
- RVNC $256,945,000.00
- UEC $17,203,000.00
- Revenue This Year
- RVNC $11.28
- UEC $45,283.93
- Revenue Next Year
- RVNC $27.21
- UEC $71.22
- P/E Ratio
- RVNC N/A
- UEC N/A
- Revenue Growth
- RVNC 25.82
- UEC N/A
- 52 Week Low
- RVNC $2.30
- UEC $4.06
- 52 Week High
- RVNC $9.75
- UEC $8.93
- Technical
- Relative Strength Index (RSI)
- RVNC 33.47
- UEC 38.63
- Support Level
- RVNC $3.06
- UEC $7.11
- Resistance Level
- RVNC $3.09
- UEC $7.70
- Average True Range (ATR)
- RVNC 0.11
- UEC 0.43
- MACD
- RVNC 0.02
- UEC -0.15
- Stochastic Oscillator
- RVNC 6.90
- UEC 3.65
About RVNC Revance Therapeutics Inc.
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.